Delayed booster dosing improves human antigen-specific Ig and B

medRxiv - The Preprint Server for Health Sciences

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine - ScienceDirect

B-cell responses to vaccination at the extremes of age

A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses

Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV- BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine - eBioMedicine

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile - ScienceDirect

Bidirectionality between Cardiometabolic Diseases and COVID-19: Role of Humoral Immunity - Advances in Nutrition

Viruses, Free Full-Text

Frontiers Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost

Profiling Germinal Center-like B Cell Responses to Conjugate Vaccines Using Synthetic Immune Organoids

CDR3 sequence analysis of PfRH5-specific B cells in DFx and

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination

New insights into human immune memory from SARS‐CoV‐2 infection and vaccination - Hartley - 2022 - Allergy - Wiley Online Library

Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination